PLETHICO

Plethico Pharmaceuticals Limited has informed the Exchange that the Trading Window for the equity shares of the Company shall remain closed from March 9, 2016 to March 16, 2016 (both days inclusive) . lnter-alia to consider and approve the audited financial results for the quarter and year ended March 31, 2015.Accordingly, all the insiders and Designated Persons (including directors and employees) and others who have come in to the receipt of any insider information are hereby directed not to deal in shares of he Company during the period of closure of Trading Window as stated above.

Plethico Pharmaceuticals Limited has informed the Exchange that pursuant to the Trading Window of the Company shall remain closed from May 22, 2015 to June 01, 2015 (both days inclusive) for designated employees for dealing in securities of the Company.

Plethico Pharmaceuticals Limited has informed the Exchange regarding Shifting of Corporate Office of the Company from Sabnam House, Plot No.A-15/16, Central Cross Road-B, M.I.D.C Andheri (E), Mumbai - 400093 to Shop No: 262, Lower Ground Floor, Dreams the Mall, L B S Marg, Bhandup (W), Mumbai - 400078.

Plethico Pharmaceuticals Limited has informed the Exchange that the Trading Window of the Company shall remain closed for the directors and designated employees covered under the Code for dealing in the securities of the Company from February 12, 2015 till twenty-four hours after making corporate announcement of the outcome of Board Meeting declaring Un-audited Financial Results for the quarter and nine months ended December 31, 2014 to the Stock Exchanges.

Plethico Pharmaceuticals Limited has informed the Exchange that pursuant to the "Company's Code of Conduct for Prevention of Insider Trading", the Trading Window of the Company shall remain closed for the directors and designated employees covered under the Code for dealing in the securities of the Company from November 12, 2014 till twenty-four hours after making corporate announcement of the outcome of Board Meeting declaring Un-audited Financial Results for the second quarter and half year ended September 30, 2014 to the Stock Exchanges.